Results 261 to 270 of about 309,486 (308)
Some of the next articles are maybe not open access.

Advances in antiviral therapy

Current Opinion in Pediatrics, 1997
For many years, acyclovir has been used to treat herpes simplex and varicella zoster infections in adults and children, although new drugs with improved bioavailability and dosage regimens (ie, famciclovir, valaciclovir) are replacing it for the outpatient management of these conditions in adults.
D E, Dwyer, A M, Kesson
openaire   +2 more sources

Antiviral Therapy in Pregnancy

Clinical Obstetrics and Gynecology, 1990
Though the reported experience with zidovudine in human pregnancies is very limited, it would seem unreasonable at this time to withhold zidovudine therapy for fetal considerations in the treatment of pregnant women with AIDS and ARC. Whether the treatment of HIV-positive women with zidovudine at any time during pregnancy reduces the risk of perinatal ...
Z A, Brown, D H, Watts
openaire   +2 more sources

Advances in antiviral therapy

Current Opinion in Pediatrics, 1999
Multiple agents for the treatment and prevention of viral illnesses have been developed during the past few years. While in many cases this has been in direct response to the human immunodeficiency virus type 1 epidemic, a number of new antiviral agents are relevant to the practice of general pediatrics.
D M, Zerr, L M, Frenkel
openaire   +2 more sources

Nephrotoxicity of antiviral therapies

Current Opinion in Nephrology and Hypertension, 1996
An ever-increasing variety of antiviral medications are being used clinically for an array of viral infections ranging from hepatitis to HIV. Some of these medications, such as acyclovir and foscarnet, have significant nephrotoxicity, whereas others are associated only rarely with renal failure.
B N, Becker, G, Schulman
openaire   +2 more sources

Antiviral therapy of influenza

Seminars in Pediatric Infectious Diseases, 2002
The prevention of influenza virus infections by the use of vaccines remains the most cost-effective and practical method of influenza virus control, but the use of antiviral prophylaxis and treatment in certain populations or high-risk individuals is also possible.
openaire   +2 more sources

Antiviral Gene Therapy

2008
This chapter describes the major gene therapeutic approaches for viral infections. The vast majority of published approaches target severe chronic viral infections such as hepatitis B or C and HIV infection. Two basic gene therapy strategies are introduced here. The first involves the expression of a protein or an RNA that inhibits viral replication by
D, von Laer, C, Baum, U, Protzer
openaire   +2 more sources

Intraocular Antiviral Therapy

Archives of Ophthalmology, 1989
In this issue of theArchives, Heinemann 1 reports the results of long-term intravitreal ganciclovir injection therapy for patients with acquired immunodeficiency syndrome (AIDS) with cytomegalovirus (CMV) retinitis. As the AIDS epidemic has grown to affect all population centers in this country, ophthalmologists have more frequently been encountering ...
openaire   +2 more sources

RNAi as an antiviral therapy

Expert Opinion on Biological Therapy, 2005
There are a dozen or so viruses that will continue to be a serious global health threat for many years to come, mainly due to their chronic nature. These include hepatitis C virus (HCV), human papillomavirus viruses (HPVs), West Nile virus and human herpes viruses (i.e., HSV, CMV, EBV, HHV-8, etc.).
openaire   +2 more sources

Antiviral therapy of influenza

Expert Opinion on Investigational Drugs, 2005
Influenza viruses are a leading cause of morbidity and mortality worldwide despite the availability of an effective vaccine. The emergence of highly pathogenic avian influenza viruses in southeast Asia, which can infect and kill humans and for which there is no vaccine, has heightened the need to establish a supply of effective antivirals.
openaire   +2 more sources

Antiviral therapy

2021
Antiviral therapy continues to be one of the many challenges facing the healthcare provider. This chapter describes viruses that parasitize host cell enzymes and structures to varying degrees and discusses the difficulty of designing or discovering drugs that specifically target viral enzymes without affecting host cell machinery.
Rajeev Shah, Cheston B. Cunha
openaire   +1 more source

Home - About - Disclaimer - Privacy